novo nordisk news - Search News

Novo Nordisk, Nvidia and Supercomputer

Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market

Lilly will launch its Mounjaro obesity drug in Denmark next week, the U.S. drugmaker said on Thursday, bringing competition to the home country of its biggest weight-loss rival, Danish pharmaceuticals group Novo Nordisk.

Investopedia · 23h

Nvidia Launches Danish Sovereign AI Supercomputer That Novo Nordisk Will Use

Pharmaceutical giant Novo Nordisk plans to use Denmark's first sovereign artificial intelligence supercomputer—powered by Nvidia technology—for drug discovery.

Bloomberg L.P. · 1d

Novo to Use New Nvidia AI Supercomputer for Drug Discovery

Denmark unveiled an Nvidia-powered supercomputer that will be used by Novo Nordisk A/S and other Danish pharmaceutical companies as they seek novel drugs and smarter trial designs.

TMCnet · 1d

Novo Nordisk Foundation announces Denmark's first AI supercomputer is now operational

New supercomputer built on NVIDIA DGX SuperPOD will accelerate research and provide new opportunities in academia and industry COPENHAGEN, Denmark, Oct. 23, 2024 /PRNewswire/ -- The new AI supercomputer,

Novo Nordisk, compounding

Reuters · 21h

Novo Nordisk asks US to stop compounding pharmacies from making weight-loss drug copies

Oct 23 (Reuters) - Novo Nordisk (NOVOb.CO) on Tuesday asked the U.S. Food and Drug Administration to ban compounding pharmacies from making copycat versions of its popular weight-loss and diabetes drugs, which it said were too complex for those manufacturers to produce safely.

Pharmaceutical Technology · 4h

Pharmacists “desperation” by Novo Nordisk over semaglutide copycat block

Novo Nordisk has asked the FDA to add semaglutide to a list that would effectively block manufacturing of copycat versions of Wegovy and Ozempic.

Yahoo · 22h

Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats

Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes treatment Ozempic,

10hon MSN

Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...

Novo Nordisk's semaglutide could also be effective against Alzheimer's

A new study is adding to evidence that GLP-1 drugs such as Novo Nordisk's semaglutide and Eli Lilly's tirzepatide could also ...

FiercePharma1d

Novo Nordisk asks FDA to prevent compounders from making copycat versions of GLP-1 star semaglutide

The war is on between compounding pharmacies making knockoff versions of popular weight loss drugs and pharma giants Novo ...

BioSpace6h

Novo’s Semaglutide Linked to Reduced Alzheimer’s Risk in Real-World Study

Researchers have linked Novo Nordisk’s semaglutide to a 40% to 70% reduction in the risk of Alzheimer’s disease diagnosis in ...

1don MSN

Novo Nordisk's Death Cross: Is A Turnaround Coming For The Ozempic, Wegovy Maker?

Novo Nordisk A/S (NYSE:NVO) just hit a technical red flag — a Death Cross. Chart created using Benzinga Pro For those ...

1don MSN

Novo Nordisk CEO Lars Jorgensen blames ‘complex US healthcare system’ for steep Ozempic prices — which Senator Bernie Sanders says may lead to higher insurance …

Novo Nordisk CEO Lars Fruergaard Jorgensen has called attention to the complexities of the U.S. healthcare system while ...

BioSpace7h

Why It’s OK to Talk About Catalent’s Pending Buyout by ‘Novo’

The group of like-named companies that include Novo Holdings and Novo Nordisk—the two tied to a multibillion-dollar buyout of Catalent currently under FTC review—ultimately send proceeds to the Novo ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Novo Nordisk, Nvidia and Supercomputer

Novo Nordisk, compounding

Related topics